PT86144A - Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith - Google Patents

Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith

Info

Publication number
PT86144A
PT86144A PT86144A PT8614487A PT86144A PT 86144 A PT86144 A PT 86144A PT 86144 A PT86144 A PT 86144A PT 8614487 A PT8614487 A PT 8614487A PT 86144 A PT86144 A PT 86144A
Authority
PT
Portugal
Prior art keywords
porocess
tsf
protein
preparation
pharmaceutical compositions
Prior art date
Application number
PT86144A
Other languages
English (en)
Other versions
PT86144B (pt
Inventor
Rainer De Martin
Adriano Fontana
Erhard Hofer
Renate Hofer-Warbinek
Michael Wrann
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT86144A publication Critical patent/PT86144A/pt
Publication of PT86144B publication Critical patent/PT86144B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT86144A 1986-11-17 1987-11-16 Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem PT86144B (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
AT305186 1986-11-17
AT327486 1986-12-10
AT333886 1986-12-16
AT334286 1986-12-16
CH526386 1986-12-31
CH526286 1986-12-31
CH296387 1987-08-03
CH330587 1987-08-28

Publications (2)

Publication Number Publication Date
PT86144A true PT86144A (en) 1987-12-01
PT86144B PT86144B (pt) 1990-08-31

Family

ID=27569993

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86144A PT86144B (pt) 1986-11-17 1987-11-16 Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem

Country Status (12)

Country Link
EP (1) EP0268561A3 (pt)
JP (1) JPH01501361A (pt)
KR (1) KR890700031A (pt)
AU (1) AU612617B2 (pt)
DK (1) DK400088D0 (pt)
FI (1) FI883363A0 (pt)
HU (1) HUT57059A (pt)
IL (1) IL84484A0 (pt)
MY (1) MY102257A (pt)
NZ (1) NZ222569A (pt)
PT (1) PT86144B (pt)
WO (1) WO1988003807A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5221734A (en) * 1987-10-01 1993-06-22 Ciba-Geigy Corporation Process for preparing a polypeptide growth factor for milk
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
US5236905A (en) * 1988-08-25 1993-08-17 Oncogen In vitro method of inhibition of HIV using transforming growth factor-.beta.
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5043431A (en) * 1989-09-11 1991-08-27 Codon Method and apparatus for the production of TGF-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
RU2386638C2 (ru) 2004-03-31 2010-04-20 Дженентек, Инк. Гуманизированные анти-тфр-бета-антитела
NZ576445A (en) 2006-11-02 2012-03-30 Daniel J Capon Hybrid immunoglobulins with moving parts
WO2018203541A1 (ja) * 2017-05-02 2018-11-08 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
AU630075B2 (en) * 1987-10-06 1992-10-22 Bristol-Myers Squibb Company Cloning and expression of transforming growth factor 2b

Also Published As

Publication number Publication date
EP0268561A2 (en) 1988-05-25
HUT57059A (en) 1991-11-28
EP0268561A3 (en) 1988-10-26
WO1988003807A3 (en) 1988-08-11
WO1988003807A2 (en) 1988-06-02
DK400088A (da) 1988-07-15
FI883363A (fi) 1988-07-14
AU612617B2 (en) 1991-07-18
JPH01501361A (ja) 1989-05-18
AU1104988A (en) 1988-06-16
IL84484A0 (en) 1988-04-29
FI883363A0 (fi) 1988-07-14
NZ222569A (en) 1990-08-28
KR890700031A (ko) 1989-03-02
MY102257A (en) 1992-05-15
PT86144B (pt) 1990-08-31
DK400088D0 (da) 1988-07-15

Similar Documents

Publication Publication Date Title
IL80411A (en) Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
IL79235A (en) Pharmaceutical compositions containing solubilized proteins and their preparation
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
IL79887A0 (en) Human insulin analogues,their preparation and pharmaceutical compositions containing them
DE3665717D1 (en) Complexes of flavanolignanes with phospholipids, preparation thereof and associated pharmaceutical compositions
ZA852864B (en) Preparation of functional human factor viii
PT82862A (en) Process for the preparation of aloes products and pharmaceutical compositions therewith
GR860342B (en) 11b- phenyl-gonane their preparation and pharmaceutical preparations containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
PT86144A (en) Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith
GR871659B (en) Substituted a-aminoacids their preparation and pharmaceutical compositions containing them
NZ222931A (en) Pharmaceutical compositions containing quinuclidine substituted benzamides and thiobenzamides
GB8705317D0 (en) Preparation of pharmaceuticals
PT82855A (en) Process for the preparation of glucopyranoses phosphonated and pharmaceutical compositions therewith
ZA872167B (en) Compounds and pharmaceutical preparations having calcium-regulatory activity
NZ216880A (en) Azabicyclo derivatives of benzamides and pharmaceutical compositions
ZA879452B (en) 5-hydroxyethyl derivatives of oxazolidinone-2,their preparation and their therapeutic uses
IL84893A0 (en) Pharmaceutical compositions containing certain derivatives of pyrano-quinoline and their preparation
PT83982A (en) Process for the preparation of new benzamides and pharmaceutical compositions thereof
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
NZ221018A (en) 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions
GB2178035B (en) Novel benzamides and their preparation and therapeutic application

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930831